financetom
Business
financetom
/
Business
/
Trevi Therapeutics Q4 Loss Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trevi Therapeutics Q4 Loss Narrows
Mar 17, 2026 1:52 PM

04:19 PM EDT, 03/17/2026 (MT Newswires) -- Trevi Therapeutics ( TRVI ) reported a Q4 loss late Tuesday of $0.06 per diluted share, narrowing from a loss of $0.11 a year earlier.

Analysts polled by FactSet expected a loss of $0.10.

The company ended the quarter with $188.3 million in cash, cash equivalents and marketable securities, providing a cash runway into 2028.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved